· Endothelial progenitor cells. A new key for endothelial dysfunction in migraine.

· Efficacy and tolerability of lasmiditan, an oral 5ht receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study.

· A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator (rtPA).

· Familial hemiplegic migraine with prolonged global aura: Follow-up findings of subtraction ictal SPECT co-registered to MRI (SISCOM).

· Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values.

· Zonisamida en el tratamiento preventivo de la migraña refractaria.

· Vascular retinal, neuroimaging and ultrasonographic markers of lacunar infarcts.

· Association Study of the Serotoninergic System in Migraine in the Spanish Population.

· Statin treatment withdrawal in ischemic stroke. Acontrolled randomized study.

· MMP-9 Immunoreactivity in acute Migraine.

· Testing the combination beta-blocker plus topiramate in refractory migraine.

· Bending the Rule of Monotheraphy for Migraine Prevention?

· Headache in Cerebral Homorrhage is Associated with Inflammatory Markers and Higher Residual Cavity.

· The impact of migraine on psyhological well-being of young women an their communication with physicians about migraine: a multinational study.

· Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome.

· The clinical-DWI mismatch. A new diagnostic approach to the brain tissue al rik of infarction.

· Early neurologic deterioration in intracerebral hemorrhage. Predictors and associated factors.

· Preventing Disturbing Migraine Aura With Lamotrigine: An Open Study.

· The impact of migraine on work, family, and leisure among young women – a multinational study.

· Almotriptan Versus Rizatriptan in Patients With Migraine in Spain.

· Combined therapy for migraine prevention? Clinical experience with a b-blocker plus sodium valproate in 52 resistant migraine patients.

· Molecular signatures of brain injury after intracerebral hemorrhage.

· Headache as a surrogate marker of the molecular mechanisms implicated in progressing stroke.

· Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis. A report of 50 cases.


· Hemorragia cerebral. Urgencias Neurológicas.

· Complicaciones de la migraña. Tratado de cefaleas.

· Cefalea atribuida a trastornos vasculares. Tratado de cefaleas.

· Cefalea en racimos crónica.

· Aproximación clínica al paciente con ictus. Evaluación general y neurológica.

· Cefalea alarmante: Criterio de consulta con el especialista.

· Investigación básica en patología cerebrovascular.¿Por ónde vamos?